Abstract
Pomalidomide + Low-Dose Dexamethasone + Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have